H. Lundbeck A/S operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other
pharmaceutical manufacturers in Europe:
Stada Arzneimittel AG
sales of 2.33 billion Euro [US$2.60 billion]
of which 59%
Hikma Pharmaceuticals PLC
of the United Kingdom
(£1.56 billion [US$2.03 billion]
of which 40%
was Injectable Pharmaceuticals), and
Croda International Plc
based in the United Kingdom
(£1.39 billion [US$1.81 billion]
of which 35%
was Personal Care).
H. Lundbeck A/S reported sales of 18.12 billion Danish Kroner (US$2.70 billion)
December of 2018.
increase of 5.1%
versus 2017, when the company's sales were 17.23 billion Danish Kroner.
This was the fourth straight year of sales growth at H. Lundbeck A/S.